6377_Front_Line_Genomics_MultiOmics_Report_V31

The Multi-Omics Playbook

Multi-omics has the potential to reach new precedents in biological discoveries. However, keeping up-to-date with the current methodologies, principles and tools can be difficult for researchers working in the field.  
 
What if a report existed that outlined the current challenges, applications and principles in multi-omics, so you could quickly and efficiently apply the new technologies to your own research?  
 
Well, there is! Our Multi-omics Playbook explores the field as it stands today to help you get to grips with key principles, technologies and applications to drive your multi-omics research forward.  
 
This comprehensive report is built around the contributions of subject-matter experts to provide you with real-life examples, useful tips, and unique perspectives. We explore the combination of various omic data types, as well as the challenges and solutions to the integration of multi-omics data, the merging of proteomics and metabolomics with other omics, and the rapid eruption of spatial multi-omics.  
Not only that, but we also speak to individuals employing multi-omics in pharma and drug discovery to understand the current state of play and to explore the potential future of the drug development field. 
  • Bruno A. Benitez, Assistant Professor of Neurology and Neuroscience, Director of the Biorepository of the Department of Neurology; Associate Member, Beth Israel Deaconess Medical Center, Harvard Medical School; Broad Institute of MIT & Harvard 
  • Mathew Chamberlain, Senior Principal Scientist, Johnson and Johnson Innovative Medicine 
  • Anthony Gitter, Associate Professor, Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison 
  • Matthias Heinig, Research Group Leader, Institute of Computational Biology; TUM Junior Fellow, Department of Computer Science, TUM School of Computation, Information and Technology, German Research Center for Environmental Health; Helmholtz Munich, Technical University of Munich
  • Kahkeshan Hijazi, PhD, Senior Expert Translational Data Scientist, Novartis Institute of Biomedical Research 
  • Johanna Jackson, Advanced Research Fellow and Alzheimer’s Society Dementia Research Leader, UK DRI at Imperial, Imperial College London 
  • Tom Lanz, Senior Director of Multi-omics and Biomarkers, Pfizer 
  • Eric Letouzé, Research Team Leader, Cancer and Immunology Research Center (CRCI2NA)  
  • Hongzhe Li, Perelman Professor of Biostatistics, Epidemiology and Informatics, University of Pennsylvania School of Medicine 
  • J. John Mann MD, Paul Janssen Professor of Translational Neuroscience in Psychiatry and Radiology; Director, Molecular Imaging and Neuropathology Division, Department of Psychiatry; Co-Director Columbia Center for Prevention and Treatment of Depression, Columbia University/New York State Psychiatric Institute 
  • Tesfaye (Tes) Mersha, Professor of Pediatrics at Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine 
  • Roberta Migale, PhD, Senior Laboratory Research Scientist, Lovell-Badge Lab, The Francis Crick Institute 
  • Michela Noseda, Reader of Cardiovascular Science, National Heart and Lung Institute, Imperial College London 
  • Irene Ong, Associate Professor, Departments of Obstetrics and Gynecology and Biostatistics and Medical Informatics, University of Wisconsin-Madison 
  • Jiwoon Park, Postdoctoral Associate, Chris Mason Laboratory and George Church Laboratory, Weill Cornell Medicine and Harvard Medical School 
  • Gennady Roshchupkin, Assistant Professor and Computational Population Biology Group Leader, Erasmus MC Medical Center 
  • Eléonore Schneegans, PhD Candidate in Bioinformatics, Jackson Group, UK DRI at Imperial, Imperial College London 
  • Raj Sewduth, Senior Post-doc, VIB-KU Leuven Center for Cancer Biology 
  • Dan Theodorescu, Director, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Cancer Centre 
  • Nikolaos Trasanidis, Computational Science Investigator; Honorary Research Fellow, GSK; Imperial College London 
Importantly, The Multi-omics Playbook is completely FREE to download. So, you can access and browse the report in your own time, easily and efficiently.

Download Report

ABOUT US       CONTACT       ADVERTISE       PRIVACY POLICY 

Front Line Genomics Limited is registered in England and Wales. Company Number 10421716, VAT: GB 297 742 548.
Registered Office: Ground Floor, Cromwell House, 15 Andover Road, Winchester, Hampshire, SO23 7BT